{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:40:47Z","timestamp":1787852447977,"version":"build-2784847793"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["transplantation-proceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.transproceed.2014.08.043","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T10:01:40Z","timestamp":1418119300000},"page":"3585-3592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Incidence, Risk Factors, and Outcomes of Delayed-Onset Cytomegalovirus Disease in a Large, Retrospective Cohort of Heart Transplant Recipients"],"prefix":"10.1016","volume":"46","author":[{"given":"C.A.Q.","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.C.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.J.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1016\/j.transproceed.2014.08.043_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in solid organ transplantation","volume":"13","author":"Razonable","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2014.08.043_bib2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2014.08.043_bib3","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/j.1600-6143.2006.01413.x","article-title":"Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients","volume":"6","author":"Khoury","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2014.08.043_bib4","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.healun.2003.08.034","article-title":"Pre-emptive treatment with oral valganciclovir in management of CMV infection after cardiac transplantation","volume":"23","author":"Devyatko","year":"2004","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2014.08.043_bib5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00007890-199803150-00026","article-title":"Preemptive treatment for the prevention of cytomegalovirus disease: in lung and heart transplant recipients","volume":"65","author":"Egan","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.08.043_bib6","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/TP.0b013e3181cee42f","article-title":"International consensus guidelines on the management of cytomegalovirus in solid organ transplantation","volume":"89","author":"Kotton","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.08.043_bib7","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1600-6143.2007.02133.x","article-title":"Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial","volume":"8","author":"Kliem","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2014.08.043_bib8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.tp.0000229039.87735.76","article-title":"Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection","volume":"82","author":"Potena","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.08.043_bib9","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1600-6143.2009.02618.x","article-title":"Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients","volume":"9","author":"Kumar","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2014.08.043_bib10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1086\/427506","article-title":"Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence","volume":"40","author":"Singh","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2014.08.043_bib11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.healun.2007.07.016","article-title":"Clinical features and outcomes of delayed-onset primary cytomegalovirus disease in cardiac transplant recipients","volume":"26","author":"Kijpittayarit-Arthurs","year":"2007","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2014.08.043_bib12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.healun.2008.02.002","article-title":"High incidence of cytomegalovirus disease in D+\/R\u2212 heart transplant recipients shortly after completion of 3 months of valganciclovir prophylaxis","volume":"27","author":"Gupta","year":"2008","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2014.08.043_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.transproceed.2014.08.043_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","article-title":"Partial residuals for the proportional hazards regression model","volume":"69","author":"Schoenfeld","year":"1982","journal-title":"Biometrika"},{"key":"10.1016\/j.transproceed.2014.08.043_bib15","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1086\/528718","article-title":"Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation","volume":"46","author":"Arthurs","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2014.08.043_bib16","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/lt.21280","article-title":"Delayed-onset primary cytomegalovirus disease after liver transplantation","volume":"13","author":"Arthurs","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2014.08.043_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11908-003-0044-4","article-title":"Gastrointestinal infections caused by cytomegalovirus","volume":"5","author":"Bobak","year":"2003","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.transproceed.2014.08.043_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1399-3062.2006.00158.x","article-title":"Acute esophageal necrosis (black esophagus) in the renal transplant recipient: manifestation of primary cytomegalovirus infection","volume":"9","author":"Trappe","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2014.08.043_bib19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1399-3062.2008.00311.x","article-title":"Antral mass due to cytomegalovirus infection requiring gastrectomy in a liver transplant recipient","volume":"10","author":"Llado","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2014.08.043_bib20","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/eurheartj\/ehp408","article-title":"Cytomegalovirus colitis 5 years after heart transplantation","volume":"30","author":"Goy","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.transproceed.2014.08.043_bib21","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/10898540-000000000-00000","article-title":"New developments in the management of cytomegalovirus infection after solid organ transplantation","volume":"70","author":"Eid","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.transproceed.2014.08.043_bib22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/01.tp.0000256335.84363.9b","article-title":"Changes in coronary arterial dimensions early after cardiac transplantation","volume":"83","author":"Fearon","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.08.043_bib23","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1086\/324516","article-title":"Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir","volume":"184","author":"Razonable","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.transproceed.2014.08.043_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/0003-4819-123-1-199507010-00002","article-title":"Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial","volume":"123","author":"Hibberd","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2014.08.043_bib25","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.2215\/CJN.05691207","article-title":"Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies","volume":"3","author":"Weiss","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2014.08.043_bib26","article-title":"2013 ACC\/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","author":"Goff","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.transproceed.2014.08.043_bib27","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.transproceed.2014.08.043_bib28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.7326\/0003-4819-159-5-201309030-00008","article-title":"Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: US Preventive Services Task Force recommendation statement","volume":"159","author":"Moyer","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2014.08.043_bib29","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2014.08.043_bib30","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.110.226936","article-title":"The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls","volume":"108","author":"Mann","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.transproceed.2014.08.043_bib31","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1099\/0022-1317-74-11-2333","article-title":"Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer\/promoter in immature monocytic cells","volume":"74","author":"Stein","year":"1993","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.transproceed.2014.08.043_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/viro.1995.1143","article-title":"Stimulation of the human cytomegalovirus IE enhancer\/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB","volume":"208","author":"Prosch","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.transproceed.2014.08.043_bib33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00007890-199409000-00007","article-title":"Cytomegalovirus infection in transplant recipients: the role of tumor necrosis factor","volume":"58","author":"Fietze","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.08.043_bib34","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/cid\/cit521","article-title":"Detection of cytomegalovirus DNA in plasma as an adjunct diagnostic for gastrointestinal tract disease in kidney and liver transplant recipients","volume":"57","author":"Durand","year":"2013","journal-title":"Clin Infect Dis"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134514009130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134514009130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T23:58:09Z","timestamp":1538006289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134514009130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0041134514009130"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.08.043","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence, Risk Factors, and Outcomes of Delayed-Onset Cytomegalovirus Disease in a Large, Retrospective Cohort of Heart Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.08.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}